Articles for AstraZeneca (LSE: AZN)

Why I’d ditch this defensive dividend stock to buy AstraZeneca plc

G A Chester argues AstraZeneca plc (LON:AZN) is the pick of two defensive dividend stocks. More »

This small-cap stock could be a better dividend buy than AstraZeneca plc

Dividend investing: should you buy AstraZeneca plc (LON:AZN) after a setback in its ‘Mystic’ clinical trial, or consider this small-cap instead? More »

Why AstraZeneca plc could have a major impact on your investment performance

AstraZeneca plc (LON: AZN) could be about to deliver vastly-improved financial performance. More »

One super dividend stock I’d buy along with AstraZeneca plc

This firm’s impressive finances make it a serious potential pairing in my portfolio with AstraZeneca plc (LON: AZN). More »

Why this dividend growth stock could be a better buy than AstraZeneca plc

Roland Head explains why he's not buying AstraZeneca plc (LON:AZN) today. More »

Why I’m not buying FTSE 100 giants AstraZeneca plc and Barclays plc for their dividends

Edward Sheldon looks at drugs giant AstraZeneca plc (LON: AZN) and banking behemoth Barclays plc (LON: BARC) and explains why he won't be investing... More »

Top stocks for August

We asked our analysts to share their top stock picks for the coming month. More »

AstraZeneca plc’s shock plunge is a buying opportunity for the brave

This could be the moment to buy AstraZeneca plc (LON: AZN) that you have been waiting for, says Harvey Jones. More »

Is AstraZeneca plc a falling knife to catch after dropping 15% today?

AstraZeneca plc (LON: AZN) could be one of best bargains of the FTSE 100 (INDEXFTSE: UKX) right now. More »

Why I’m considering FTSE 100 income and growth champion AstraZeneca plc

AstraZeneca plc (LSE: AZN) looks attractive to me today. More »

2 FTSE 100 stocks for retirement income AND growth

These two FTSE 100 (INDEXFTSE:UKX) stocks could deliver above-average income and strong capital growth. More »

2 FTSE 100 dividend stocks I’d buy in May

Roland Head highlights two stocks with the potential for long-term income growth. More »

Does cancer breakthrough make this stock a better buy than AstraZenenca plc?

Should investors ditch AstraZeneca plc (LON:AZN) in favour of this promising AIM-listed biotech firm? More »

2 ‘evergreen’ Neil Woodford picks I’d buy now

These two stalwarts could power your portfolio for years to come. More »

2 FTSE 100 growth giants that could fund your retirement

These two rising FTSE 100 (INDEXFTSE:UKX) stocks could help you to a comfortable old age. More »

1 FTSE 100 stock I’d buy in April, and 1 I’d avoid

I'd rate these two as one of the best and one of the worst in the FTSE 100 (INDEXFTSE:UKX). More »

2 Neil Woodford stocks I’d buy in an instant

These two Neil Woodford stocks could deliver high returns. More »

Is this top FTSE 100 income stock a clear takeover candidate?

Could this company find itself a takeover target once again? More »

These 2 bargain dividend stocks could beat the FTSE 100 in 2017

Improving financial performance could allow these two stocks to outperform the FTSE 100 (INDEXFTSE:UKX). More »

Now Neil Woodford owns just eight FTSE stocks!

Renowned blue-chip master Neil Woodford now owns just eight FTSE 100 (INDEXFTSE: UKX) stocks. More »